Analysts’ Viewpoint on Clinical Laboratory Services Market Scenario
Increase in burden of chronic diseases, rise in demand for early diagnosis, and rapid technological advancements in pathology are driving the global clinical laboratory services market. Clinical laboratories help analyze body fluid samples, such as blood, urine, or DNA samples, and identify possible disease-causing genetic changes. Of late, at-home and rapid diagnostic tests have been gaining traction across the globe, especially after the onset of the COVID-19 disease. Growth of the digital pathology market and rise in preference for comprehensive health checkups are expected to augment the global market during the forecast period. Key players operating in the market are enhancing their molecular and pathology capabilities to broaden their revenue streams.
Clinical laboratories offer information about patient health. Clinical tests aid physicians to identify the root cause of diseases and subsequently provide appropriate treatment. Clinical laboratory services include various types of tests such as clinical chemistry, medical microbiology & cytology, genetics, and toxicology. Clinical chemistry deals with the analysis of body fluids, while medical microbiology and cytology help diagnose various medical conditions including infection, inflammation, or cancer. Genetic and genomic research lab services facilitate the discovery of causative variants relevant to disease pathophysiology.
Chronic disorders such as cardiovascular diseases, obesity, cancer, and diabetes are affecting several people across the globe. Sedentary lifestyle, pollution, aging population, and climate change are some of the major factors that influence the emergence of diseases worldwide. According to the Centers for Disease Control and Prevention (CDC), more than 60% of preventable deaths worldwide are caused due to non-communicable diseases. In developing countries, 48% of such deaths occur in people above 70 years of age. As per the World Health Organization (WHO), each year, more than 13 million deaths around the world are caused by avoidable environmental causes. Thus, high prevalence of diseases is expected to boost the demand for clinical laboratory testing during the forecast period.
Life expectancy has increased significantly, especially in developed countries, due to the rise in access to better healthcare facilities and growth in healthcare expenditure. This has led to a surge in geriatric population across the globe. According to the WHO, around 524 million people were aged 65 or above, accounting for 8% of the world’s population, in 2010. A threefold rise in this number is expected by 2050, propelling the geriatric population to 1.5 billion, representing 16% of the global population. Surge in geriatric population has led to an increase in cases of age-related disorders. This, in turn, is boosting the volume of clinical tests performed annually. People aged 50 years and above are susceptible to various disorders such as cancer, diabetes, and cardiovascular diseases.
Based on test type, the global clinical laboratory services market has been segmented into clinical chemistry, medical microbiology & cytology, food intolerance test, human & tumor genetics, and other esoteric tests. According to the recent clinical laboratory service trends, the clinical chemistry segment is expected to dominate the global market during the forecast period. Expansion of the clinical chemistry market in emerging economies and surge in awareness about early disease diagnosis are driving the segment. Clinical chemistry plays a vital role in the diagnosis of various diseases. Advancements in mass spectrometry and flow cytometry have revolutionized clinical chemistry analysis.
The medical microbiology & cytology segment is expected to grow significantly during the forecast period. Clinical microbiology laboratory services include monitoring and analysis of microbial cultures and samples. Rise in cases of infectious diseases across the world is fueling the segment.
In terms of service provider, the clinical laboratory services market has been divided into stand-alone laboratories, hospital-based laboratories, contract research organizations (CROs), and others. The stand-alone laboratories segment is likely to hold the largest share of the market during the forecast period. Increase in number of private laboratories and rise in investments in clinical laboratory management are driving the segment.
North America is anticipated to dominate the global market during the forecast period. Rise in healthcare expenditure in the public as well as the private sector and increase in prevalence of lifestyle-related diseases are fueling the market in the region. The market in Europe is expected to grow at a CAGR of more than 5.7% during 2022 to 2031.
Asia Pacific is projected to be the fastest-growing market for clinical laboratory services during the forecast period, with a CAGR of more than 7.3%. India and China are poised to be the growth engines for the market in the region. Growth of the medical tourism market, rise in geriatric population, and increase in prevalence of various diseases are prominent factors driving the market in Asia Pacific. The market in Australia and Japan is anticipated to witness favorable growth in the next few years.
Key players operating in the global clinical laboratory services market are engaged in product launches, collaborations, partnerships, and mergers & acquisitions to enhance their market share. They are also investing significantly in R&D activities to stay competitive in the market. Charles River Laboratories International, Inc., SYNLAB International GmbH, Sonic Healthcare, NeoGenomics Laboratories, Inc., Genomic Health, Inc., Fresenius Medical Care AG & Co. KGaA, Laboratory Corporation of America Holdings, Unilabs, Quest Diagnostics Incorporated, and Eurofins Scientific SE are the key entities operating in this market.
Attribute | Detail |
---|---|
Market Size Value in 2021 | US$ 313.3 Bn |
Market Forecast Value in 2031 | More than US$ 561.1 Bn |
Compound Annual Growth Rate (CAGR) | 5.9% |
Forecast Period | 2022-2031 |
Historical Data Available for | 2017-2021 |
Quantitative Units | US$ Bn for Value |
Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
Competition Landscape |
|
Format | Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope | Available upon request |
Pricing | Available upon request |
The global clinical laboratory services market was valued at US$ 313.3 Bn in 2021
The global clinical laboratory services market is projected to reach more than US$ 561.1 Bn by 2031
The global clinical laboratory services market is anticipated to grow at a CAGR of 5.9% from 2022 to 2031
Rise in incidence of chronic and infectious diseases, and increase in geriatric population
Charles River Laboratories International, Inc., SYNLAB International GmbH, Sonic Healthcare, NeoGenomics Laboratories, Inc., Genomic Health, Inc., Fresenius Medical Care AG & Co. KGaA, Laboratory Corporation of America Holdings, Unilabs, Quest Diagnostics Incorporated, and Eurofins Scientific SE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Clinical Laboratory Services Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Clinical Laboratory Services Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Mergers & Acquisitions
5.3. Healthcare Industry Overview
5.4. Covid19 Impact Analysis
6. Global Clinical Laboratory Services Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Test Type, 2017-2031
6.3.1. Clinical Chemistry
6.3.2. Medical Microbiology & Cytology
6.3.3. Food Intolerance Test
6.3.4. Human & Tumor Genetics
6.3.5. Other Esoteric Tests
6.4. Market Attractiveness Analysis, by Test Type
7. Global Clinical Laboratory Services Market Analysis and Forecast, by Service Provider
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Service Provider, 2017-2031
7.3.1. Stand-alone Laboratories
7.3.2. Hospital-based Laboratories
7.3.3. Contract Research Organizations (CROs)
7.3.4. Others
7.4. Market Attractiveness Analysis, by Service Provider
8. Global Clinical Laboratory Services Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Clinical Laboratory Services Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Test Type, 2017-2031
9.2.1. Clinical Chemistry
9.2.2. Medical Microbiology & Cytology
9.2.3. Food Intolerance Test
9.2.4. Human & Tumor Genetics
9.2.5. Other Esoteric Tests
9.3. Market Value Forecast, by Service Provider, 2017-2031
9.3.1. Stand-alone Laboratories
9.3.2. Hospital-based Laboratories
9.3.3. Contract Research Organizations (CROs)
9.3.4. Others
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Test Type
9.5.2. By Service Provider
9.5.3. By Country
10. Europe Clinical Laboratory Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Test Type, 2017-2031
10.2.1. Clinical Chemistry
10.2.2. Medical Microbiology & Cytology
10.2.3. Food Intolerance Test
10.2.4. Human & Tumor Genetics
10.2.5. Other Esoteric Tests
10.3. Market Value Forecast, by Service Provider, 2017-2031
10.3.1. Stand-alone Laboratories
10.3.2. Hospital-based Laboratories
10.3.3. Contract Research Organizations (CROs)
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Test Type
10.5.2. By Service Provider
10.5.3. By Country/Sub-region
11. Asia Pacific Clinical Laboratory Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Test Type, 2017-2031
11.2.1. Clinical Chemistry
11.2.2. Medical Microbiology & Cytology
11.2.3. Food Intolerance Test
11.2.4. Human & Tumor Genetics
11.2.5. Other Esoteric Tests
11.3. Market Value Forecast, by Service Provider, 2017-2031
11.3.1. Stand-alone Laboratories
11.3.2. Hospital-based Laboratories
11.3.3. Contract Research Organizations (CROs)
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Test Type
11.5.2. By Service Provider
11.5.3. By Country/Sub-region
12. Latin America Clinical Laboratory Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Test Type, 2017-2031
12.2.1. Clinical Chemistry
12.2.2. Medical Microbiology & Cytology
12.2.3. Food Intolerance Test
12.2.4. Human & Tumor Genetics
12.2.5. Other Esoteric Tests
12.3. Market Value Forecast, by Service Provider, 2017-2031
12.3.1. Stand-alone Laboratories
12.3.2. Hospital-based Laboratories
12.3.3. Contract Research Organizations (CROs)
12.3.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Test Type
12.5.2. By Service Provider
12.5.3. By Country/Sub-region
13. Middle East & Africa Clinical Laboratory Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Test Type, 2017-2031
13.2.1. Clinical Chemistry
13.2.2. Medical Microbiology & Cytology
13.2.3. Food Intolerance Test
13.2.4. Human & Tumor Genetics
13.2.5. Other Esoteric Tests
13.3. Market Value Forecast, by Service Provider, 2017-2031
13.3.1. Stand-alone Laboratories
13.3.2. Hospital-based Laboratories
13.3.3. Contract Research Organizations (CROs)
13.3.4. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Test Type
13.5.2. By Service Provider
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2021)
14.3. Company Profiles
14.3.1. Charles River Laboratories International, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Analysis
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. SYNLAB International GmbH
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Analysis
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Sonic Healthcare
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Analysis
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. NeoGenomics Laboratories, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Analysis
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Genomic Health, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Analysis
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. Fresenius Medical Care AG & Co. KGaA
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Analysis
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. Laboratory Corporation of America Holdings
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Analysis
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. Unilabs
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Analysis
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
14.3.9. Quest Diagnostics Incorporated
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Analysis
14.3.9.3. Growth Strategies
14.3.9.4. SWOT Analysis
14.3.10. Eurofins Scientific SE
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Analysis
14.3.10.3. Growth Strategies
14.3.10.4. SWOT Analysis
List of Tables
Table 01: Global Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 02: Global Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2031
Table 03: Global Clinical Laboratory Services Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 05: North America Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2031
Table 06: North America Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 07: Europe Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 08: Europe Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2031
Table 09: Europe Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 10: Asia Pacific Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 11: Asia Pacific Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2031
Table 12: Asia Pacific Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 13: Latin America Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 14: Latin America Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2031
Table 15: Latin America Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 16: Middle East & Africa Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 17: Middle East & Africa Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2031
Table 18: Middle East & Africa Clinical Laboratory Services Market Value (US$ Mn) Forecast, by Country, 2017-2031
List of Figures
Figure 01: Global Clinical Laboratory Services, by Test Type, Market Size (US$ Mn), 2021
Figure 02: Global Market Revenue (%), by Service Provider, 2021
Figure 03: Distribution of Clinical Laboratory Services Market by Region, 2021 and 2031
Figure 04: Global Clinical Laboratory Services Market Size (US$ Mn) Forecast, 2017-2031
Figure 05: Porter’s Five Forces Analysis
Figure 06: Global Market Value Share, by Test Type (2021)
Figure 07: Global Market Value Share, by Service Provider (2021)
Figure 08: Australia Country - Profile
Figure 09: U.S. - Country Profile
Figure 10: UAE - Country Profile
Figure 11: U.K. - Country Profile
Figure 12: Brazil - Country Profile
Figure 13: India -Country Profile
Figure 14: Global Clinical Laboratory Services Market Value Share Analysis, by Test Type, 2021 and 2031
Figure 15: Global Clinical Laboratory Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Clinical Chemistry, 2017-2031
Figure 16: Global Clinical Laboratory Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medical Microbiology & Cytology, 2017-2031
Figure 17: Global Clinical Laboratory Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Food Intolerance Test, 2017-2031
Figure 18: Global Clinical Laboratory Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Human & Tumor Genetics, 2017-2031
Figure 19: Global Clinical Laboratory Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Esoteric Test, 2017-2031
Figure 20: Global Clinical Laboratory Services Market Attractiveness Analysis, by Test Type
Figure 21: Global Clinical Laboratory Services Market Value Share Analysis, by Service Provider, 2021 and 2031
Figure 22: Global Clinical Laboratory Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stand-alone Laboratories, 2017-2031
Figure 23: Global Clinical Laboratory Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital-based Laboratories, 2017-2031
Figure 24: Global Clinical Laboratory Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CROs, 2017-2031
Figure 25: Global Clinical Laboratory Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
Figure 26: Global Clinical Laboratory Services Market Attractiveness Analysis, by Service Provider
Figure 27: Global Clinical Laboratory Services Market Scenario
Figure 28: Global Clinical Laboratory Services Market Value Share Analysis, by Region, 2021 and 2031
Figure 29: Global Clinical Laboratory Services Market Attractiveness Analysis, by Region
Figure 30: North America Clinical Laboratory Services Market Size (US$ Mn) Forecast, 2017-2031
Figure 31: North America Clinical Laboratory Services Market Value Share Analysis, by Test Type, 2021 and 2031
Figure 32: North America Clinical Laboratory Services Market Value Share Analysis, by Service Provider, 2021 and 2031
Figure 33: North America Clinical Laboratory Services Market Value Share Analysis, by Country, 2021 and 2031
Figure 34: North America Clinical Laboratory Services Market Attractiveness Analysis, by Test Type, 2017-2031
Figure 35: North America Clinical Laboratory Services Market Attractiveness Analysis, by Service Provider, 2017-2031
Figure 36: North America Clinical Laboratory Services Market Attractiveness Analysis, by Country, 2017-2031
Figure 37: Europe Clinical Laboratory Services Market Size (US$ Mn) Forecast, 2017-2031
Figure 38: Europe Clinical Laboratory Services Market Value Share Analysis, by Test Type, 2021 and 2031
Figure 39: Europe Clinical Laboratory Services Market Value Share Analysis, by Service Provider, 2021 and 2031
Figure 40: Europe Clinical Laboratory Services Market Value Share Analysis, by Country, 2021 and 2031
Figure 41: Europe Clinical Laboratory Services Market Attractiveness Analysis, by Test Type, 2017-2031
Figure 42: Europe Clinical Laboratory Services Market Attractiveness Analysis, by Service Provider, 2017-2031
Figure 43: Europe Clinical Laboratory Services Market Attractiveness Analysis, by Country, 2017-2031
Figure 44: Asia Pacific Clinical Laboratory Services Market Size (US$ Mn) Forecast, 2017-2031
Figure 45: Asia Pacific Clinical Laboratory Services Market Value Share Analysis, by Test Type, 2021 and 2031
Figure 46: Asia Pacific Clinical Laboratory Services Market Value Share Analysis, by Service Provider, 2021 and 2031
Figure 47: Asia Pacific Clinical Laboratory Services Market Value Share Analysis, by Country, 2021 and 2031
Figure 48: Asia Pacific Clinical Laboratory Services Market Attractiveness Analysis, by Test Type, 2017-2031
Figure 49: Asia Pacific Clinical Laboratory Services Market Attractiveness Analysis, by Service Provider, 2017-2031
Figure 50: Asia Pacific Clinical Laboratory Services Market Attractiveness Analysis, by Country, 2017-2031
Figure 51: Latin America Clinical Laboratory Services Market Size (US$ Mn) Forecast, 2017-2031
Figure 52: Latin America Clinical Laboratory Services Market Value Share Analysis, by Test Type, 2021 and 2031
Figure 53: Latin America Clinical Laboratory Services Market Value Share Analysis, by Service Provider, 2021 and 2031
Figure 54: Latin America Clinical Laboratory Services Market Value Share Analysis, by Country, 2021 and 2031
Figure 55: Latin America Clinical Laboratory Services Market Attractiveness Analysis, by Test Type, 2017-2031
Figure 56: Latin America Clinical Laboratory Services Market Attractiveness Analysis, by Service Provider, 2017-2031
Figure 57: Latin America Clinical Laboratory Services Market Attractiveness Analysis, by Country, 2017-2031
Figure 58: Middle East & Africa Clinical Laboratory Services Market Size (US$ Mn) Forecast, 2017-2031
Figure 59: Middle East & Africa Clinical Laboratory Services Market Value Share Analysis, by Test Type, 2021 and 2031
Figure 60: Middle East & Africa Clinical Laboratory Services Market Value Share Analysis, by Service Provider, 2021 and 2031
Figure 61: Middle East & Africa Clinical Laboratory Services Market Value Share Analysis, by Country, 2021 and 2031
Figure 62: Middle East & Africa Clinical Laboratory Services Market Attractiveness Analysis, by Test Type, 2017-2031
Figure 63: Middle East & Africa Clinical Laboratory Services Market Attractiveness Analysis, by Service Provider, 2017-2031
Figure 64: Middle East & Africa Clinical Laboratory Services Market Attractiveness Analysis, by Country, 2017-2031